Clinical Trials Logo

Strabismus clinical trials

View clinical trials related to Strabismus.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06035757 Not yet recruiting - Pediatric ALL Clinical Trials

The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery

Start date: September 15, 2023
Phase: Phase 4
Study type: Interventional

The present tiral conduted to demonstrate the administration of sugammadex as reversal of neuromuscular blockade agent reduces the incedence of emergence agitation (EA) comparing to neostigmine

NCT ID: NCT05883280 Not yet recruiting - Emergence Delirium Clinical Trials

The Effect of Binaural Sound on the Occurrence of Emergence Delirium in Children Undergoing Strabismus Surgery

Start date: May 20, 2023
Phase: N/A
Study type: Interventional

The hypothesis of this study is that providing continuous binaural beats with a phase difference in alpha frequency during anesthesia can reduce the incidence of emergence agitation in pediatric patients. To test this hypothesis, the occurrence of emergence agitation will be compared between the group that received binaural beats and the group that did not receive binaural beats.

NCT ID: NCT05882643 Not yet recruiting - Strabismus Clinical Trials

Deep Neuromuscular Blockade in Strabismus Surgery

Start date: May 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if inducing a moderate or greater neuromuscular block (TOF count 0-3) when performing a neuromuscular block in pediatric patients aged 3 to 18 years undergoing strabismus surgery under general anesthesia can reduce the incidence of the oculocardiac reflex.

NCT ID: NCT05522595 Not yet recruiting - Clinical trials for Binocular Vision Disorder

Performance and Safety Evaluation of the S360 Medical Device Software.

ArgoS360
Start date: November 2, 2023
Phase: N/A
Study type: Interventional

The aim of this interventional, cross-sectional study is to evaluate the performance and the safety of the medical device software S360. This clinical investigation is performed in order to demonstrate the conformity of the medical device, when operating under the normal conditions of its intended use, in accordance with the General Safety and Performance Requirements pertaining to clinical evaluation of the device regarding the Medical Device Regulation (MDR) 2017/745 (EU).

NCT ID: NCT04927468 Not yet recruiting - Clinical trials for Graves Ophthalmopathy

Supramaximal Rectus Recession for Strabismus in Grave's Ophthalmopathy

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate supramaximal rectus recession for strabismus in Grave's Ophthalmopathy

NCT ID: NCT04919694 Not yet recruiting - Clinical trials for Thyroid Associated Ophthalmopathy

Combination of Orbital Compression Surgery and Strabismus Surgery for Thyroid Associated Ophthalmopathy

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether combination of orbital compression surgery with strabismus surgery is better than strabismus surgery after orbital compression surgery in the treatment of moderate-to-severe thyroid associated ophthalmopathy

NCT ID: NCT04782960 Not yet recruiting - Anesthesia, Local Clinical Trials

Subconjunctival Bupivacaine in Strabismus Surgery

Start date: April 2021
Phase: N/A
Study type: Interventional

This study aimed to assess the effectiveness of the Subconjunctival bupivacaine on postoperative pain in Strabismus surgery under general anaesthesia.

NCT ID: NCT04213768 Not yet recruiting - Strabismus Clinical Trials

Lateral Rectus Resection Versus Lateral Rectus Plication in Patients With Residual Esotropia

Start date: December 2019
Phase: N/A
Study type: Interventional

In this study, the surgical outcomes of lateral rectus plication and resection techniques on patients with residual esotropia will be compared. Methods: In this randomized clinical trial, a total of 57 patients with residual esotropia (31 females and 26 males) who were candidate for lateral rectus resection are going to be included and randomized into plication and resection groups. The inclusion criteria will be residual esotropia after uni- or bilateral medial rectus recession, or unilateral recession and resection (R&R). Subjects with a history of prematurity, lack of central fixation, extraocular muscle palsy, systemic, ocular disorders, follow up less than three months will be excluded. A comprehensive ophthalmic examinations are going to be conducted preoperatively and at 1, 3 and 6 months' follow-ups. Surgical success rate will be considered in cases with a postoperative eso- or exotropia ≤10pd.

NCT ID: NCT03266549 Not yet recruiting - Clinical trials for Large Angle Horizontal Strabismus

Botulinum Toxin Augmented Surgery vs Conventional Surgery in the Management of Large Angle Horizontal Deviations

Start date: February 20, 2021
Phase: N/A
Study type: Interventional

Horizontal strabismus includes esotropia and exotropia where there is inward or outward deviation of visual axes of the eyes respectively. The most common initial treatment of horizontal strabismus is either bilateral rectus muscle recessions or unilateral recession resection surgery. For large angle deviations (>50 prism diopters [PD]), surgery on 2 muscles alone may not be adequate with high reoperation rates. Approaches to these patients included large bilateral muscle recessions, supramaximal unilateral recession resection procedure, three or four horizontal muscle surgery, or botulinum toxin augmented surgery. Botulinum toxin augmentated strabismus surgery was reported in several studies. Owens et al.reported successful botulinum toxin augmentation of monocular recession-resection surgeries in 3 large-angle exotropia patients with successful results in two of the 3 patients. Khan reported 8 patients with > 60 PD esotropia treated with botulinum-augmented surgery. Six of 8 had deviations of 10 PD or less following surgery. Özkan et al used botulinum augmentation in a group of older patients with large angle esotropia of different etiologies, with a success rate of 57%. Lueder et al evaluated the long-term outcomes in patients with infantile esotropia. The results were good, with a 74% success rate. Based on historical comparisons, this technique appears equally as effective as 3- or 4-muscle surgery and more effective than large bilateral medial rectus recessions alone. Ideally, a prospective randomized study should be performed to more definitively determine the effectiveness of intraoperative botulinum toxin augmentation compared to surgery alone.

NCT ID: NCT02810847 Not yet recruiting - Amblyopia Clinical Trials

The Use of Interactive Binocular Treatment (I-BiT) for the Management of Anisometropic, Strabismic and Mixed Amblyopia in Children Aged 3.5 - 12 Years

I-BiT Plus
Start date: June 2016
Phase: N/A
Study type: Interventional

Around one child in fifty has a lazy eye (termed amblyopia) where the eye is structurally normal but the vision fails to develop correctly. Around half of these children also have a squint (strabismus) where each eye has a different direction of gaze. This condition is the commonest cause of visual impairment in one eye in children. This is a randomised control trial of wearing glasses alone (which will result in some visual improvement, termed refractive adaptation) and wearing glasses combined with using I-BiT Plus. The hypothesis is that using I-BiT Plus will result in an improved visual outcome.